|
J. Biol. Chem., Vol. 266, Issue 22, 14383-14389, Aug, 1991
Attenuation of cAMP-mediated responses in MA-10 Leydig tumor cells by genetic manipulation of a cAMP-phosphodiesterase [published erratum appears in J Biol Chem 1992 Jan 25;267(3):2114]
JV Swinnen, B D'Souza, M Conti and M Ascoli
Department of Pediatrics, University of North Carolina, Chapel Hill 27599.
In order to assess the effect of increased cAMP degradation on the
responsiveness on an endocrine cell, we have obtained stable transfectants
of MA-10 Leydig tumor cells that overexpress a mammalian
cAMP-phosphodiesterase. Two novel cell lines, designated MA-10(P+8) and
MA-10(P+29), that express high levels of the transfected enzyme were
characterized. Although the basal levels of cAMP in the mutant cell lines
are comparable to those of the wild-type cells, the increase in cAMP
accumulation elicited by human choriogonadotropin (hCG) is severely
blunted. Further studies with MA-10(P+29) show that the ability of hCG to
stimulate adenylyl cyclase activity is normal. The failure of MA-10(P+29)
cells to accumulate cAMP in response to hCG can be correlated with a
similar reduction in hCG-stimulated steroidogenesis. On the other hand, the
maximal steroidogenic response of MA-10(P+29) cells to dibutyryl cAMP, a
cAMP analogue that is fairly resistant to phosphodiesterase degradation, is
normal. We also show that the ability of these cells to respond to hCG with
increased cAMP accumulation and steroid synthesis can be restored with a
specific phosphodiesterase inhibitor. These results demonstrate that
overexpression of a cAMP-phosphodiesterase in MA-10 cells limits the levels
of cAMP attained under hCG stimulation and supresses the steroidogenic
response of these cells to hCG. Since gonadotropins increase the
cAMP-phosphodiesterase activity in their target cells, these findings also
provide evidence that this regulation plays a major role in the modulation
of cell responsiveness. Last, these new cell lines should be valuable in
the study of the actions of cAMP because they express a conditional and
reversible cAMP-resistant phenotype.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. Vasta, M. Shimizu-Albergine, and J. A. Beavo
Modulation of Leydig cell function by cyclic nucleotide phosphodiesterase 8A
PNAS,
December 26, 2006;
103(52):
19925 - 19930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Giembycz and R. Newton
Beyond the dogma: novel {beta}2-adrenoceptor signalling in the airways.
Eur. Respir. J.,
June 1, 2006;
27(6):
1286 - 1306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ammoun, L. Johansson, M. E. Ekholm, T. Holmqvist, A. S. Danis, L. Korhonen, O. A. Sergeeva, H. L. Haas, K. E. O. Akerman, and J. P. Kukkonen
OX1 Orexin Receptors Activate Extracellular Signal-Regulated Kinase in Chinese Hamster Ovary Cells via Multiple Mechanisms: The Role of Ca2+ Influx in OX1 Receptor Signaling
Mol. Endocrinol.,
January 1, 2006;
20(1):
80 - 99.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R S Bhaskaran and M Ascoli
The post-endocytotic fate of the gonadotropin receptors is an important determinant of the desensitization of gonadotropin responses
J. Mol. Endocrinol.,
April 1, 2005;
34(2):
447 - 457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hirakawa and M. Ascoli
The Lutropin/Choriogonadotropin Receptor-Induced Phosphorylation of the Extracellular Signal-Regulated Kinases in Leydig Cells Is Mediated by a Protein Kinase A-Dependent Activation of Ras
Mol. Endocrinol.,
November 1, 2003;
17(11):
2189 - 2200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yoshida, L. Beltran-Parrazal, P. Butler, M. Conti, A. C. Charles, and R. I. Weiner
Lowering Cyclic Adenosine-3',5'-Monophosphate (cAMP) Levels by Expression of a cAMP-Specific Phosphodiesterase Decreases Intrinsic Pulsatile Gonadotropin-Releasing Hormone Secretion from GT1 Cells
Mol. Endocrinol.,
October 1, 2003;
17(10):
1982 - 1990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Paruthiyil, M. E. Majdoubi, M. Conti, and R. I. Weiner
Phosphodiesterase expression targeted to gonadotropin-releasing hormone neurons inhibits luteinizing hormone pulses in transgenic rats
PNAS,
December 24, 2002;
99(26):
17191 - 17196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hirakawa, C. Galet, and M. Ascoli
MA-10 Cells Transfected with the Human Lutropin/Choriogonadotropin Receptor (hLHR): A Novel Experimental Paradigm to Study the Functional Properties of the hLHR
Endocrinology,
March 1, 2002;
143(3):
1026 - 1035.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mehats, G. Tanguy, E. Dallot, D. Cabrol, F. Ferre, and M.-J. Leroy
Is Up-Regulation of Phosphodiesterase 4 Activity by PGE2 Involved in the Desensitization of {beta}-Mimetics in Late Pregnancy Human Myometrium?
J. Clin. Endocrinol. Metab.,
November 1, 2001;
86(11):
5358 - 5365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Oki, S.-I. Takahashi, H. Hidaka, and M. Conti
Short Term Feedback Regulation of cAMP in FRTL-5 Thyroid Cells. ROLE OF PDE4D3 PHOSPHODIESTERASE ACTIVATION
J. Biol. Chem.,
April 6, 2000;
275(15):
10831 - 10837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-L. C. Jin, F. J. Richard, W.-P. Kuo, A. J. D'Ercole, and M. Conti
Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice
PNAS,
October 12, 1999;
96(21):
11998 - 12003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-L. C. Jin, T. Bushnik, L. Lan, and M. Conti
Subcellular Localization of Rolipram-sensitive, cAMP-specific Phosphodiesterases. DIFFERENTIAL TARGETING AND ACTIVATION OF THE SPLICING VARIANTS DERIVED FROM THE PDE4D GENE
J. Biol. Chem.,
July 31, 1998;
273(31):
19672 - 19678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. B. Bolger, I. McPhee, and M. D. Houslay
Alternative Splicing of cAMP-specific Phosphodiesterase mRNA Transcripts
J. Biol. Chem.,
January 12, 1996;
271(2):
1065 - 1071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Grange, C. Sette, M. Cuomo, M. Conti, M. Lagarde, A.-F. Prigent, and G. Nemoz
The cAMP-specific Phosphodiesterase PDE4D3 Is Regulated by Phosphatidic Acid Binding. CONSEQUENCES FOR cAMP SIGNALING PATHWAY AND CHARACTERIZATION OF A PHOSPHATIDIC ACID BINDING SITE
J. Biol. Chem.,
October 20, 2000;
275(43):
33379 - 33387.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1991 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|